As SFRP5 does reduce production of proinflammatory TNFα, IL-6, and MCP-1, we expect it to exert anti-inflammatory effect in obesity related lung injury. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.